Clinical Trials Directory

Trials / Completed

CompletedNCT02276573

Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Oral lichen planus (OLP) is a chronic inflammatory and relapsing. The average prevalence is 1 to 4%. The clinics forms are many and symptoms are varied. The erosive form, painful and debilitating is characterized by erosive areas, ulcerated on an erythematous base with or without a keratinocyte lichenien network. The literature data moving towards an autoimmune origin, but the pathophysiological mechanisms of OLP remain unknown. This project represents the first part of a comprehensive project to examine the oral pathogenesis of different viruses (Herpes and papillomavirus HPV) and centered on Epstein-Barr Virus (EBV).

Conditions

Interventions

TypeNameDescription
BIOLOGICALbuccal cavity sample

Timeline

Start date
2015-03-30
Primary completion
2016-03-10
Completion
2016-03-10
First posted
2014-10-28
Last updated
2026-03-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02276573. Inclusion in this directory is not an endorsement.

Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus (NCT02276573) · Clinical Trials Directory